Antibodies
30 July 2009
GLAXOSMITHKLINE AND GENMAB ANNOUNCE TOP-LINE RESULTS FOR OFATUMUMAB IN RHEUMATOID ARTHRITIS30 July 2009
Second Phase III Study Showed Lucentis Improved Vision in Patients with Retinal Vein Occlusion24 July 2009
Merck KGaA Considers Appealing CHMP Opinion on Erbitux ATreatment for Non-Small Cell Lung Cancer20 July 2009
Nycomed announces FDA filing for Daxas® in COPDNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports